Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1050 participants.

Also called NCT04505618

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 1,050 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04505618
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04505618. Non-randomized; single masking; primary purpose screening. Start 2019-10-01 (actual); primary completion 2027-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
Acronym
OCTA-RVD
Condition
Diabetic Retinopathy
Condition
Retinal Vein Occlusion
Condition
Hypertension,Essential
Condition
Retinal Vascular Disorder
Intervention (Device)
Swept-Source (SS) OCT Angiography
Intervention (Device)
Spectral-Domain (SD) OCT Angiography
Intervention (Device)
Fundus Imaging
Intervention (Device)
Axial Length Measurement Device
Lead sponsor
Johns Hopkins University (class: other)
Collaborator
National Eye Institute (NEI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct04505618
Content hash
86c98881267e2684bb36710ddaea38a30137dd2ef137484db2c4a3c2c42074c7